- call +1-201-465-4211
- email sales@mrinsights.biz
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
Scope of the Report:
This report focuses on the Non-Invasive Cancer Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Non-Invasive Cancer Diagnostics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
CTCs
CTNAS
Exosomes
Market Segment by Applications, can be divided into
Blood
Urine
Saliva
There are 15 Chapters to deeply display the global Non-Invasive Cancer Diagnostics market.
Chapter 1, to describe Non-Invasive Cancer Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Non-Invasive Cancer Diagnostics, with sales, revenue, and price of Non-Invasive Cancer Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Non-Invasive Cancer Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Non-Invasive Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Non-Invasive Cancer Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Non-Invasive Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 CTCs
1.2.2 CTNAS
1.2.3 Exosomes
1.3 Market Analysis by Applications
1.3.1 Blood
1.3.2 Urine
1.3.3 Saliva
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gen-Probe Inc
2.1.1 Business Overview
2.1.2 Non-Invasive Cancer Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Digene Corporation
2.2.1 Business Overview
2.2.2 Non-Invasive Cancer Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Quest Diagnostics Inc
2.3.1 Business Overview
2.3.2 Non-Invasive Cancer Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Cancer, Genetics Inc
2.4.1 Business Overview
2.4.2 Non-Invasive Cancer Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BIOVIEW Inc
2.5.1 Business Overview
2.5.2 Non-Invasive Cancer Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AVIVA Biosciences Corporation
2.6.1 Business Overview
2.6.2 Non-Invasive Cancer Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Laboratory Corporation of America Holdings (LabCorp)
2.7.1 Business Overview
2.7.2 Non-Invasive Cancer Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 A&G Pharmaceutical
2.8.1 Business Overview
2.8.2 Non-Invasive Cancer Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Affymetrix Inc
2.9.1 Business Overview
2.9.2 Non-Invasive Cancer Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Precision Therapeutics
2.10.1 Business Overview
2.10.2 Non-Invasive Cancer Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Non-Invasive Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Non-Invasive Cancer Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Non-Invasive Cancer Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Non-Invasive Cancer Diagnostics Manufacturer Market Share in 2017
3.3.2 Top 6 Non-Invasive Cancer Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Non-Invasive Cancer Diagnostics Market Analysis by Regions
4.1 Global Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Regions
4.1.1 Global Non-Invasive Cancer Diagnostics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Non-Invasive Cancer Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
5 North America Non-Invasive Cancer Diagnostics by Countries
5.1 North America Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Countries
5.1.1 North America Non-Invasive Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Non-Invasive Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
6 Europe Non-Invasive Cancer Diagnostics by Countries
6.1 Europe Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Countries
6.1.1 Europe Non-Invasive Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Non-Invasive Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Non-Invasive Cancer Diagnostics by Countries
7.1 Asia-Pacific Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Non-Invasive Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Non-Invasive Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
8 South America Non-Invasive Cancer Diagnostics by Countries
8.1 South America Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Countries
8.1.1 South America Non-Invasive Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Non-Invasive Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Non-Invasive Cancer Diagnostics by Countries
9.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Non-Invasive Cancer Diagnostics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Non-Invasive Cancer Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Non-Invasive Cancer Diagnostics Sales and Growth Rate (2013-2018)
10 Global Non-Invasive Cancer Diagnostics Market Segment by Type
10.1 Global Non-Invasive Cancer Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Non-Invasive Cancer Diagnostics Sales and Market Share by Type (2013-2018)
10.1.2 Global Non-Invasive Cancer Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 CTCs Sales Growth and Price
10.2.1 Global CTCs Sales Growth (2013-2018)
10.2.2 Global CTCs Price (2013-2018)
10.3 CTNAS Sales Growth and Price
10.3.1 Global CTNAS Sales Growth (2013-2018)
10.3.2 Global CTNAS Price (2013-2018)
10.4 Exosomes Sales Growth and Price
10.4.1 Global Exosomes Sales Growth (2013-2018)
10.4.2 Global Exosomes Price (2013-2018)
11 Global Non-Invasive Cancer Diagnostics Market Segment by Application
11.1 Global Non-Invasive Cancer Diagnostics Sales Market Share by Application (2013-2018)
11.2 Blood Sales Growth (2013-2018)
11.3 Urine Sales Growth (2013-2018)
11.4 Saliva Sales Growth (2013-2018)
12 Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.1 Global Non-Invasive Cancer Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Non-Invasive Cancer Diagnostics Market Forecast by Regions (2018-2023)
12.2.1 North America Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.2.2 Europe Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.2.4 South America Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Non-Invasive Cancer Diagnostics Market Forecast (2018-2023)
12.3 Non-Invasive Cancer Diagnostics Market Forecast by Type (2018-2023)
12.3.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Type (2018-2023)
12.3.2 Global Non-Invasive Cancer Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Non-Invasive Cancer Diagnostics Market Forecast by Application (2018-2023)
12.4.1 Global Non-Invasive Cancer Diagnostics Sales Forecast by Application (2018-2023)
12.4.2 Global Non-Invasive Cancer Diagnostics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Non-Invasive Cancer Diagnostics Picture
Table Product Specifications of Non-Invasive Cancer Diagnostics
Figure Global Sales Market Share of Non-Invasive Cancer Diagn
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
